徐凯虹,周罗根,程宝金.匹多莫德辅助治疗婴幼儿支原体肺炎疗效观察及免疫功能变化.[J].中南医学科学杂志.,2016,(3):299-302.
匹多莫德辅助治疗婴幼儿支原体肺炎疗效观察及免疫功能变化
Effect of Pidotimod on Infantile Mycoplasma Pneumonia and Immunologic Function
投稿时间:2015-11-29  修订日期:2016-04-06
DOI:
中文关键词:  婴幼儿支原体肺炎  匹多莫德  T淋巴细胞亚群  细胞因子  免疫球蛋白
英文关键词:infantile Mycoplasma pneumonia  Pidotimod  T cell subpopulations  Cytokines  Immune globulin
基金项目:
作者单位
徐凯虹 南京医科大学附属常州市第二人民医院儿科,江苏 常州 213003 
周罗根 南京医科大学附属常州市第二人民医院儿科,江苏 常州 213003 
程宝金 南京医科大学附属常州市第二人民医院儿科,江苏 常州 213003 
摘要点击次数: 654
全文下载次数: 530
中文摘要:
      目的 探讨匹多莫得辅助治疗对婴幼儿支原体肺炎患儿的T淋巴细胞亚群的百分比的影响及细胞因子和免疫球蛋白表达的变化。方法选取100例婴幼儿支原体肺炎患儿,随机分为观察组(n=50)和对照组(n=50)。对照组给予红霉素治疗,观察组采用红霉素联合匹多莫德治疗,比较两组患儿T淋巴细胞亚群、血清细胞因子、血清免疫球蛋白及临床疗效。结果与对照组比较,观察组患儿外周血中CD3+、CD4+和CD4+/CD8+细胞数显著升高,而CD8+细胞数则显著下降,两组间比较,其差异有显著性(P<0.05);观察组患儿血清中白细胞介素(IL)-12、IFN-γ的水平显著升高,而IL-6和IL-8的水平则明显下降(P<0.05);此外,观察组患儿血清IgM、IgG和IgA的水平较对照组增高(P<0.05),并且观察组的临床疗效要优于对照组(92.0% vs 66.0%,P<0.05)。结论匹多莫得佐治婴幼儿支原体肺炎,可显著改善患儿免疫功能,提高临床疗效,值得临床推广使用。
英文摘要:
      Objective To evaluate the effect of pidotimod on T cell subpopulations,cytokines and immune globulin in infantile Mycoplasma pneumonia.Methods100 infantile Mycoplasma pneumonia were randomly divided into control group (n=50) and observation group (n=50).Pidotimod combined with erythromycin were used in observation group and erythromycin alone was used in control group.The T cell subpopulations,serum cytokines,serum immune globulin and clinical efficacy were compared between the two groups.ResultsAfter treatment,the CD3+,CD4+,CD4+/CD8+ of observation group significantly increased,and CD8+ were significantly reduced,statistically significant difference compared with control group(P<0.05).The observation group serum IL-12,IFN-γ significantly increased,and IL-6,IL-8 were significantly reduced,statistically significant difference compared with control group(P<0.05).The levels of IgM,IgG and IgA in observation group were significantly increased,statistically significant difference compared with control group(P<0.05).The clinical efficacy of observation group was better than control group(92.0% vs 66.0%),showed significant differences between the two groups(P<0.05).ConclusionUsing pidotimod treatment infantile Mycoplasma pneumonia can improve immune function,enhance curative effect,worth clinical promotion.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FF4EC6B96077DFE7962F2ECF24D98CA6CF5CF72B3F6A4B572543EBA26C69B26DD79117C83A9D4A9B2C7462691C7D3104CE1AC4D8F89C97D3E973EB35C5D197A2FB3A1922E919D3A74CFA7EB1498481B7&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=9F915C6F01DE79C5&aid=FBC5DD826B3C539C5D2CF30922204AFE&vid=&iid=38B194292C032A66&sid=BF112261B65CB9C9&eid=119B6C0AA09DE6B9&fileno=20160316&flag=1&is_more=0">